December 4, 2019 / 3:06 AM / 2 months ago

IN BRIEF: CMS’ letters to Ipsen over Medicaid rebate warrant judicial review – D.C. Circuit

Two letters by the Centers for Medicare and Medicaid Services, rejecting Ipsen BioPharmaceuticals’ reading of a Medicaid rebate regulation, constitute a final agency action, the U.S. Court of Appeals for the District of Columbia held on Tuesday.

Reversing a win for CMS, the appeals court said the letters are subject to judicial review because they “significantly increased (Ipsen’s) risk of a statutory civil penalty.”

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below